Edition:
United States

ZIOPHARM Oncology Inc (ZIOP.OQ)

ZIOP.OQ on NASDAQ Stock Exchange Capital Market

3.18USD
3:59pm EST
Change (% chg)

$0.10 (+3.25%)
Prev Close
$3.08
Open
$3.13
Day's High
$3.26
Day's Low
$3.07
Volume
422,223
Avg. Vol
316,751
52-wk High
$5.24
52-wk Low
$1.91

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep '18 0.00 -0.132
Jun '18 0.00 -0.124
Mar '18 0.15 -0.150
FY 2017 Dec '17 1.60 -0.130
Sep '17 1.60 -0.125
Jun '17 1.60 -0.131
Mar '17 1.60 -0.150
FY 2016 Dec '16 1.60 -0.113
Sep '16 1.60 -0.111
Jun '16 1.70 -1.006
Mar '16 1.97 -0.092
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-18 4 0.20 0.80 0.00 1.32
Quarter Ending Mar-19 3 1.63 4.90 0.00 --
Year Ending Dec-18 4 0.26 0.90 0.00 5.41
Year Ending Dec-19 3 1.07 3.20 0.00 6.40
Earnings (per share)
Quarter Ending Dec-18 4 -0.11 -0.08 -0.14 -0.16
Quarter Ending Mar-19 4 -0.09 -0.08 -0.09 --
Year Ending Dec-18 4 -0.51 -0.49 -0.55 -0.60
Year Ending Dec-19 4 -0.32 -0.26 -0.36 -0.66
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 95.96 30.88
P/E High - Last 5 Yrs. -- 287.89 46.69
P/E Low - Last 5 Yrs. -- 90.15 25.78
Beta 1.49 0.66 0.95
Price to Sales (TTM) 282.64 242.95 21.76
Price to Book (MRQ) -- 18.87 4.53
Price to Tangible Book (MRQ) 122.70 22.13 11.76
Price to Cash Flow (TTM) -- 54.67 22.24
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 0.39 1.60
Dividend Yield - 5 Year Avg -- 0.20 1.42
Dividend 5 Year Growth Rate -- 3.31 -8.76
Payout Ratio(TTM) -- 6.79 44.03

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -100.00 156.34 6.54
Sales (TTM) vs TTM 1 Yr. Ago -72.72 61.53 5.26
Sales - 5 Yr. Growth Rate 51.52 24.06 7.59
EPS (MRQ) vs Qtr. 1 Yr. Ago -5.58 196.06 22.50
EPS (TTM) vs TTM 1 Yr. Ago -3.24 -- --
EPS - 5 Yr. Growth Rate -- 23.46 7.64
Capital Spending - 5 Yr. Growth Rate -13.92 37.07 8.38

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 3.57 2.63
Current Ratio (MRQ) 0.78 6.87 3.68
LT Debt to Equity (MRQ) 0.00 16.70 9.53
Total Debt to Equity (MRQ) 0.00 21.89 13.39
Interest Coverage (TTM) -35.61 -289.65 33.85

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 31.33 50.91
Gross Margin - 5 Yr. Avg. -- 47.59 52.22
EBITD Margin (TTM) -3,101.43 -- --
EBITD - 5 Yr. Avg -2,216.63 -141.70 16.27
Operating Margin (TTM) -3,131.38 -1,638.83 -15.11
Operating Margin - 5 Yr. Avg. -2,227.85 -155.53 11.89
Pre-Tax Margin (TTM) -3,092.89 -1,574.14 -13.67
Pre-Tax Margin - 5 Yr. Avg. -2,169.56 -157.11 12.22
Net Profit Margin (TTM) -3,092.89 -1,572.92 -17.11
Net Profit Margin - 5 Yr. Avg. -2,169.56 -158.05 8.44
Effective Tax Rate (TTM) -- 15.93 21.73
Effective Tax Rate - 5 Yr. Avg. -- 19.64 24.41

Efficiency

  Company industry sector
Revenue/Employee (TTM) 37,891 28,103,806 878,349,382
Net Income/Employee (TTM) -1,171,935 -3,710,889 102,474,711
Receivable Turnover (TTM) 3.37 9.19 5.49
Inventory Turnover (TTM) -- 2.64 3.99
Asset Turnover (TTM) 0.02 0.46 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -58.80 0.35 11.06
Return on Assets - 5 Yr. Avg. -90.89 2.90 11.85
Return on Investment (TTM) -102.70 0.60 13.80
Return on Investment - 5 Yr. Avg. -107.37 2.87 15.17
Return on Equity (TTM) -- -2.18 15.29
Return on Equity - 5 Yr. Avg. -657.81 -0.88 16.29
  1 Year 3 Year 5 Year
Sales % -6.88 66.95 51.52
EPS (TTM) % 59.54 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for ZIOPHARM Oncology Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 77.44 77.47 99 99
13 Week 19.72 29.34 91 94
26 Week -21.72 -21.50 49 96
52 Week -20.46 -22.85 50 98
YTD -16.43 -16.69 55 94
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 46.76%
# of Holders: 175
Total Shares Held: 66,572,751
3 Mo. Net Change: 8,891,649
# New Positions: 15
# Closed Positions: 15
# Increased Positions: 59
# Reduced Positions: 57
# Net Buyers: 2
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.